Convergent evolution of chromatin modification by structurally distinct enzymes: Comparative enzymology of histone H3 Lys27 methylation by human polycomb repressive complex 2 and vSET

Biochemical Journal

Volumn 453, Issue 2, 2013, Pages 241-247

  Swalm, Brooke M ^a   Hallenbeck, Kenneth K ^a   Majer, Christina R ^a   Jin, Lei ^a   Scott, Margaret Porter ^a   Moyer, Mikel P ^a   Copeland, Robert A ^a   Wigle, Tim J ^a  

^a EPIZYME INC   (United States)

Author keywords

Convergent evolution; Enhancer of zeste homologue 2 (EZH2); Epigenetics; Histone H3 Lys27 (H3K27); Methyltransferase; vSET

Indexed keywords

HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; VSET PROTEIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; HISTONE METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BIOCATALYSIS; CHROMATIN; HISTONES; HUMANS; LYSINE; METHYLATION; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84879580827     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130439     Document Type: Article

References (39)

1. Zhang, X. and Bruice, T. C. (2008) Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases. Proc. Natl. Acad. Sci. U.S.A. 105, 5728-5732 (Pubitemid 351758440)
2. Smith, B. C. and Denu, J. M. (2009) Chemical mechanisms of histone lysine and arginine modifications. Biochim. Biophys. Acta 1789, 45-57
3. Richon, V. M., Johnston, D., Sneeringer, C. J., Jin, L., Majer, C. R., Elliston, K., Jerva, L. F., Scott, M. P. and Copeland, R. A. (2011) Chemogenetic analysis of human protein methyltransferases. Chem. Biol. Drug Des. 78, 199-210
4. Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H. et al. (2010) Structural biology of human H3K9 methyltransferases. PLoS ONE 5, e8570
5. Rathert, P., Dhayalan, A., Murakami, M., Zhang, X., Tamas, R., Jurkowska, R., Komatsu, Y., Shinkai, Y., Cheng, X. and Jeltsch, A. (2008) Protein lysine methyltransferase G9a acts on non-histone targets. Nat. Chem. Biol. 4, 344-346 (Pubitemid 351693993)
6. Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G., Otte, A. P. et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629
7. Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G., Otte, A. P., Hayes, D. F. et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 100, 11606-11611 (Pubitemid 37205983)
8. Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E. and Helin, K. (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323-5335 (Pubitemid 37279943)
9. Simon, J. A. and Lange, C. A. (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 647, 21-29
10. Morin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F. et al. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42, 181-185
11. Sneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M. and Copeland, R. A. (2010) Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 107, 20980-20985
12. Yap, D. B., Chu, J., Berg, T., Schapira, M., Cheng, S. W., Moradian, A., Morin, R. D., Mungall, A. J., Meissner, B., Boyle, M. et al. (2011) Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117, 2451-2459
13. Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M. et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298-303
14. McCabe, M. T., Graves, A. P., Ganji, G., Diaz, E., Halsey, W. S., Jiang, Y., Smitheman, K. N., Ott, H. M., Pappalardi, M. B., Allen, K. E. et al. (2012) Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc. Natl. Acad. Sci. U.S.A. 109, 2989-2994
15. Shen, X., Liu, Y., Hsu, Y. J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G. C. and Orkin, S. H. (2008) EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 32, 491-502
16. Manzur, K. L., Farooq, A., Zeng, L., Plotnikova, O., Koch, A. W., Sachchidanand and Zhou, M. M. (2003) A dimeric viral SET domain methyltransferase specific to Lys27 of histone H3. Nat. Struct. Biol. 10, 187-196 (Pubitemid 36297988)
17. Qian, C., Wang, X., Manzur, K., Sachchidanand, Farooq, A., Zeng, L., Wang, R. and Zhou, M. M. (2006) Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase. J. Mol. Biol. 359, 86-96
18. Mujtaba, S., Manzur, K. L., Gurnon, J. R., Kang, M., Van Etten, J. L. and Zhou, M. M. (2008) Epigenetic transcriptional repression of cellular genes by a viral SET protein. Nat. Cell. Biol. 10, 1114-1122
19. Li, J., Wei, H. and Zhou, M. M. (2011) Structure-guided design of a methyl donor cofactor that controls a viral histone H3 lysine 27 methyltransferase activity. J. Med. Chem. 54, 7734-7738
20. Wei, H. and Zhou, M. M. (2010) Dimerization of a viral SET protein endows its function. Proc. Natl. Acad. Sci. U.S.A. 107, 18433-18438
21. Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J. et al. (2012) A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat. Chem. Biol. 8, 890-896
22. McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., Della Pietra, 3rd, A., Diaz, E. et al. (2012) EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108-112
23. Kuriyan, J., Krishna, T. S., Wong, L., Guenther, B., Pahler, A., Williams, Jr, C. H. and Model, P. (1991) Convergent evolution of similar function in two structurally divergent enzymes. Nature 352, 172-174 (Pubitemid 21896724)
24. Gherardini, P. F., Wass, M. N., Helmer-Citterich, M. and Sternberg, M. J. (2007) Convergent evolution of enzyme active sites is not a rare phenomenon. J. Mol. Biol. 372, 817-845 (Pubitemid 47321792)
25. Fang, J., Wang, H. and Zhang, Y. (2004) Purification of histone methyltransferases from HeLa cells. Methods Enzymol. 377, 213-226 (Pubitemid 38166817)
26. Min, D. H., Yeo, W. S. and Mrksich, M. (2004) A method for connecting solution-phase enzyme activity assays with immobilized format analysis by mass spectrometry. Anal. Chem. 76, 3923-3929
27. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K I) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108
28. Margueron, R., Li, G., Sarma, K., Blais, A., Zavadil, J., Woodcock, C. L., Dynlacht, B. D. and Reinberg, D. (2008) Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 32, 503-518
29. Reference deleted
30. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of zeste protein. Genes Dev. 16, 2893-2905 (Pubitemid 35334738)
31. Cao, R. and Zhang, Y. (2004) SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15, 57-67 (Pubitemid 38850219)
32. Margueron, R., Justin, N., Ohno, K., Sharpe, M. L., Son, J., Drury, 3rd, W. J., Voigt, P., Martin, S. R., Taylor, W. R., De Marco, V. et al. (2009) Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 461, 762-767
33. Xu, C., Bian, C., Yang, W., Galka, M., Ouyang, H., Chen, C., Qiu, W., Liu, H., Jones, A. E., MacKenzie, F. et al. (2010) Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2). Proc. Natl. Acad. Sci. U.S.A. 107, 19266-19271
34. Verreault, A., Kaufman, P. D., Kobayashi, R. and Stillman, B. (1996) Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4. Cell 87, 95-104 (Pubitemid 26337394)
35. Murzina, N. V., Pei, X. Y., Zhang, W., Sparkes, M., Vicente-Garcia, J., Pratap, J. V., McLaughlin, S. H., Ben-Shahar, T. R., Verreault, A., Luisi, B. F. and Laue, E. D. (2008) Structural basis for the recognition of histone H4 by the histone-chaperone RbAp46. Structure 16, 1077-1085
36. Copeland, R. A. (2005) Evaluation of Enzyme Inhibitors in Drug Discovery. A Guide for Medicinal Chemists and Pharmacologists, John Wiley and Sons, Hoboken
37. Purich, D. L. (2010) Enzyme Kinetics Catalysis and Control: a Reference of Theory and Best-Practice Methods, Academic Press, Amsterdam
38. Wigle, T. J., Knutson, S. K., Jin, L., Kuntz, K. W., Pollock, R. M., Richon, V. M., Copeland, R. A. and Scott, M. P. (2011) The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states. FEBS Lett. 585, 3011-3014
39. Majer, C. R., Jin, L., Scott, M. P., Knutson, S. K., Kuntz, K. W., Keilhack, H., Smith, J. J., Moyer, M. P., Richon, V. M., Copeland, R. A. and Wigle, T. J. (2012) A687V EZH2 is a gain-of-function mutation found in lymphoma patients. FEBS Lett. 586, 3448-3451